Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major

Infection and Immunity

Volumn 70, Issue 1, 2002, Pages 240-248

  Cote Sierra, J ^a   Bredan, A ^a   Toldos, C M ^a   Stijlemans, B ^a   Brys, L ^a   Cornelis, P ^a   Segovia, M ^a   De Baetselier, P ^a   Revets, H ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; LIPOPROTEIN; LIPOPROTEIN ORPI; PROTEIN GP63; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; IMMUNE RESPONSE; IMMUNITY; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, PROTOZOAN; BACTERIAL PROTEINS; DISEASE SUSCEPTIBILITY; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIPIDS; LIPOPROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTOZOAN VACCINES; PSEUDOMONAS AERUGINOSA; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036137176     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.1.240-248.2002     Document Type: Article

References (47)

1. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
2. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
3. Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant
4. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
5. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis
6. Molecular cloning of the major surface antigen of Leishmania
7. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli
8. A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination
9. In vitro simulation of immunosuppression caused by Trypanosoma brucei: Active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression
10. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccines
11. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA
12. Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12
13. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants
14. The instructive role of innate immunity in the acquired immune response
15. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α
16. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
17. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
18. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a Th1 type of immune response
19. Production of interferon-gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
20. Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis
21. Release of outer membrane fragments from normally growing Escherichia coli
22. Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in αβ T-cell receptor transgenic mice
23. Recent trends in vaccine development and immunization
24. Interferon-gamma and tumor necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis
25. Identification of a 25-amino acid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system
26. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant
27. TNF-α reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leismaniasis
28. Immunobiology of experimental cutaneous leishmaniasis
29. First generation leishmaniasis vaccines in clinical development: Moving but what next?
30. A randomized, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
31. The human immune response during cutaneous leishmaniasis: NO problem
32. IL-12 is not required for induction of type-1 cytokine responses in viral infections
33. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF-alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
34. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct
35. The regulation of immunity to Leishmania major
36. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
37. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis
38. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-alpha
39. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice
40. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
41. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist
42. Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever
43. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis
44. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: Dependence on lipid modification
45. Rapidly fatal leishmaniasis in resistant C57B1/6 mice lacking TNF
46. -)
47. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (Gp63) from Leishmania major